Amber Nigam is CEO and cofounder of basys.ai, a Harvard-based company streamlining prior authorization for health plans with generative AI. A few years ago, artificial intelligence (AI) promised to ...
Pulmonary embolism accounts for 10–15% of all paediatric venous thromboembolism (VTE) events, with an annual incidence of 0·14–0·9 per 100 000 children.1,2 Although rare, pulmonary embolism is a ...
Using information in medical records for more than 1,100 emergency room visits, researchers at Johns Hopkins Children's Center say they have developed a scoring tool that helps more accurately predict ...
On January 6, 2026, the FDA issued a Guidance for Industry and Food and Drug Administration Staff regarding Clinical Decision Support (CDS) software. The January 2026 guidance supersedes the previous, ...
Artificial Intelligence in Clinical Decision-Making: Regulatory Roadmap and Reimbursement Strategies
Artificial intelligence is rapidly transforming clinical medicine, with AI-powered tools increasingly being used for diagnostic imaging interpretation, clinical decision support, predictive analytics ...
Multi-AI agents – multiple artificial intelligence agents working together in a shared environment – can be used to address persistent workflow challenges in clinical decision support, drawing from ...
The National Institutes of Health (NIH) on Friday issued a final rule that its leaders said is expected to result in “rapid increases” in the percentage of trials registered and shared via ...
WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health today unveiled the next generation of clinical decision support (CDS) solutions, bringing together point-of-care decision support, workflow ...
To ensure that clinical trial innovation continues, regulators, industry, and other stakeholders must continue to embrace a shared vision for modernizing the innovation ecosystem in which clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results